Skip Navigation
PrintDownload PDFGet Adobe ReaderDownload to WordDownload as HTMLDownload as XMLCitation Manager
Save to Favorites
Measure Summary
Title
Diagnosis and treatment of ischemic stroke: percentage of ischemic stroke patients who are assessed with a swallow screening test before receiving food, fluids or medications by mouth.
Source(s)
Anderson D, Larson D, Bluhm J, Charipar R, Fiscus L, Hanson M, Larson J, Rabinstein A, Wallace G, Zinkel A. Diagnosis and initial treatment of ischemic stroke. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2012 Jul. 122 p. [238 references]
Jump ToGuideline ClassificationRelated Content

Measure Domain

Primary Measure Domain
Clinical Quality Measures: Process
Secondary Measure Domain
Does not apply to this measure

Brief Abstract

Description

This measure is used to assess the percentage of ischemic stroke patients age 18 years and older initially presenting with acute symptoms of ischemic stroke who are assessed with a swallow screening test before receiving food, fluids or medications by mouth.

Rationale

The priority aim addressed by this measure is to increase the percentage of stroke patients age 18 years and over who receive appropriate medical management within the initial 24 to 48 hours of diagnosis for prevention of complications such as:

  • Dehydration
  • Aspiration
  • Hypoglycemia and hyperglycemia
  • Deep vein thrombosis
  • Immobility
  • Falling
  • Nutritional status decline
  • Hyperthermia

Stroke is the fourth leading cause of death, recently dropping from third after decades long efforts to reduce incidence by treatment of risk factors. It remains the leading cause of disability among adults. Costs of hospitalizations, other cares and lost wages are simply enormous.

Pneumonia is a common finding among patients with acute stroke, its incidence ranging from 6% to 32%, and it is associated with stroke-related dysphagia symptoms. Implementation of a coordinated swallow evaluation on all acute stroke patients has been shown to significantly decrease the incidence of pneumonia among patients with acute stroke. Adherence with use of a dysphagia screening tool for patients with acute stroke has been shown to be variable with up to 25% of patients not screened. When implemented, failing a dysphagia screen has been found to be a predictor of post-stroke pneumonia. Lack of standardized, high-quality tools has hampered implementation, and a review found only four of 35 protocols met basic quality criteria. Those four protocols included the Barnes Jewish Hospital Stroke Dysphagia Screen, the modified Mann Assessment of Swallowing Ability, the Emergency Physician Swallowing Screen and Toronto Bedside Swallowing Screen Test. Lack of consensus around the best tools to use has also led the Joint Commission to retire the dysphagia screen measure as a performance indicator for certification as a Primary Stroke Center.

Evidence for Rationale
Anderson D, Larson D, Bluhm J, Charipar R, Fiscus L, Hanson M, Larson J, Rabinstein A, Wallace G, Zinkel A. Diagnosis and initial treatment of ischemic stroke. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2012 Jul. 122 p. [238 references]

Lakshminarayan K, Tsai AW, Tong X, Vazquez G, Peacock JM, George MG, Luepker RV, Anderson DC. Utility of dysphagia screening results in predicting poststroke pneumonia. Stroke 2010 Dec;41(12):2849-54. PubMed External Web Site Policy

Odderson IR, Keaton JC, McKenna BS. Swallow management in patients on an acute stroke pathway: quality is cost effective. Arch Phys Med Rehabil 1995 Dec;76(12):1130-3. PubMed External Web Site Policy

Perry L, Love CP. Screening for dysphagia and aspiration in acute stroke: a systematic review. Dysphagia 2001 Winter;16(1):7-18. [48 references] PubMed External Web Site Policy

Schepp SK, Tirschwell DL, Miller RM, Longstreth WT Jr. Swallowing screens after acute stroke: a systematic review. Stroke 2012 Mar;43(3):869-71. PubMed External Web Site Policy
Primary Health Components

Ischemic stroke; dysphagia; swallow screening

Denominator Description

Number of all patients presenting with symptoms of acute ischemic stroke (see the related "Denominator Inclusions/Exclusions" field)

Numerator Description

Number of patients who were screened for dysphagia before taking any food, fluids or medication (including aspirin) by mouth

Evidence Supporting the Measure

Type of Evidence Supporting the Criterion of Quality for the Measure
  • A clinical practice guideline or other peer-reviewed synthesis of the clinical research evidence
Additional Information Supporting Need for the Measure

Unspecified

Extent of Measure Testing

Unspecified

National Guideline Clearinghouse Link

State of Use of the Measure

State of Use
Current routine use
Current Use
Internal quality improvement

Application of the Measure in its Current Use

Measurement Setting
Emergency Medical Services
Hospitals
Professionals Involved in Delivery of Health Services
Physicians
Least Aggregated Level of Services Delivery Addressed
Single Health Care Delivery or Public Health Organizations
Statement of Acceptable Minimum Sample Size
Unspecified
Target Population Age

Age greater than or equal to 18 years

Target Population Gender
Either male or female

National Strategy for Quality Improvement in Health Care

National Quality Strategy Aim
Better Care
National Quality Strategy Priority
Prevention and Treatment of Leading Causes of Mortality

Institute of Medicine (IOM) National Health Care Quality Report Categories

IOM Care Need
Getting Better
IOM Domain
Effectiveness

Data Collection for the Measure

Case Finding Period

The time frame pertaining to data collection is monthly.

Denominator Sampling Frame
Patients associated with provider
Denominator (Index) Event or Characteristic
Clinical Condition
Encounter
Patient/Individual (Consumer) Characteristic
Denominator Time Window
Does not apply to this measure
Denominator Inclusions/Exclusions

Inclusions
Number of all patients presenting with symptoms of acute ischemic stroke

Population Definition: Patients age 18 years and older.

Exclusions
Unspecified

Exclusions/Exceptions
Unspecified
Numerator Inclusions/Exclusions

Inclusions
Number of patients who were screened for dysphagia before taking any food, fluids or medication (including aspirin) by mouth

Exclusions
Unspecified

Numerator Search Strategy
Fixed time period or point in time
Data Source
Paper medical record
Type of Health State
Does not apply to this measure
Instruments Used and/or Associated with the Measure

Unspecified

Computation of the Measure

Measure Specifies Disaggregation
Does not apply to this measure
Scoring
Rate/Proportion
Interpretation of Score
Desired value is a higher score
Allowance for Patient or Population Factors
Unspecified
Standard of Comparison
Internal time comparison

Identifying Information

Original Title

Percentage of ischemic stroke patients who are assessed with a swallow screening test before receiving food, fluids or medications by mouth.

Submitter
Institute for Clinical Systems Improvement - Nonprofit Organization
Developer
Institute for Clinical Systems Improvement - Nonprofit Organization
Funding Source(s)

The Institute for Clinical Systems Improvement's (ICSI's) work is funded by the annual dues of the member medical groups and five sponsoring health plans in Minnesota and Wisconsin.

Composition of the Group that Developed the Measure

Work Group Members: David Anderson, MD (Work Group Co-Leader) (University of Minnesota Physicians and Hennepin County Medical Center) (Neurology); David Larson, MD, FACEP (Work Group Co-Leader) (Ridgeview Medical Center) (Emergency Medicine); Gail Wallace, NP (Essentia Health) (Nursing); Lynne Fiscus, MD, MPH (Fairview Health Services) (Internal Medicine and Pediatrics); Andrew Zinkel, MD (HealthPartners Medical Group and Regions Hospital) (Emergency Medicine); Ron Charipar, MD (Marshfield Clinic) (Internal Medicine and Pediatrics); Alejandro Rabinstein, MD (Mayo Clinic) (Neurology); Jeff Larson, PharmD (Park Nicollet Health Services) (Pharmacy); Myounghee Hanson, BA (Institute for Clinical Systems Improvement) (Clinical Systems Improvement Facilitator); Jim Bluhm, MPH (Institute for Clinical Systems Improvement) (Team Director)

Financial Disclosures/Other Potential Conflicts of Interest

David Anderson, MD (Work Group Leader)
Professor, Neurology Department, Neurology, University of Minnesota Physicians and Hennepin County Medical Center
National, Regional, Local Committee Affiliations: NNINDS NHLBI as an event adjudicator for two clinical trials: SAMMPRIS (Stenting Versus Aggressive Medical Management for Preventing Recurrent Stroke), and AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL Cholesterol/High Triglyceride and Impact on Global Health Outcomes)
Guideline-Related Activities: None
Research Grants: None
Financial/Non-Financial Conflicts of Interest: MN Acute Stroke Systems Council, MDH and member of MN Time Critical Care Committee, MDH

Ron Charipar, MD (Work Group Member)
Professor, Internal Medicine, Marshfield Clinic
National, Regional, Local Committee Affiliations: None
Guideline-Related Activities: None
Research Grants: None
Financial/Non-Financial Conflicts of Interest: None

Lynne Fiscus, MD, MPH (Work Group Member)
Internal Medicine and Pediatrics, Department, Fairview Health Services
National, Regional, Local Committee Affiliations: None
Guideline-Related Activities: None
Research Grants: None
Financial/Non-Financial Conflicts of Interest: None

David Larson, MD, FACEP (Work Group Member)
Medical Director, Ridgeview Emergency Department, Ridgeview Medical Center
National, Regional, Local Committee Affiliations: None
Guideline-Related Activities: None
Research Grants: None
Financial/Non-Financial Conflicts of Interest: Clinical Advisory Panel Leader, TogetherMD, LLC, MN Acute Stroke Systems Council, MDH and member of MN Time Critical Care Committee, MDH

Jeff Larson, PharmD (Work Group Member)
Staff Pharmacist, Pharmacy, Park Nicollet Health Services
National, Regional, Local Committee Affiliations: None
Guideline-Related Activities: None
Research Grants: None
Financial/Non-Financial Conflicts of Interest: None

Alejandro Rabinstein, MD (Work Group Member)
Professor, Neurology, Mayo Clinic
National, Regional, Local Committee Affiliations: None
Guideline-Related Activities: None
Research Grants: Cardionet, MCOT use for an investigator-initiated project
Financial/Non-Financial Conflicts of Interest: Member of the Data Safety Monitoring Board for the PREVAIL study by ARTITECH (now Boston Scientific)

Gail Wallace, NP (Work Group Member)
Neurology Nurse Practitioner, Nursing, Essentia Health East Region
National, Regional, Local Committee Affiliations: None
Guideline-Related Activities: None
Research Grants: None
Financial/Non-Financial Conflicts of Interest: None

Andrew Zinkel, MD (Work Group Member)
Section Head and Medical Director of Quality, Department of Emergency Medicine, HealthPartners Medical Group and Regions Hospital
National, Regional, Local Committee Affiliations: None
Guideline-Related Activities: None
Research Grants: None
Financial/Non-Financial Conflicts of Interest: Clinical Advisory Panel Leader, TogetherMD, LLC

Adaptation

This measure was not adapted from another source.

Date of Most Current Version in NQMC
2012 Jul
Measure Maintenance

Scientific documents are revised every 12 to 24 months as indicated by changes in clinical practice and literature.

Date of Next Anticipated Revision

The next scheduled revision will occur within 24 months.

Measure Status

This is the current release of the measure.

Source(s)
Anderson D, Larson D, Bluhm J, Charipar R, Fiscus L, Hanson M, Larson J, Rabinstein A, Wallace G, Zinkel A. Diagnosis and initial treatment of ischemic stroke. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2012 Jul. 122 p. [238 references]
Measure Availability

The individual measure, "Percentage of Ischemic Stroke Patients Who Are Assessed with a Swallow Screening Test Before Receiving Food, Fluids or Medications by Mouth," is published in "Health Care Guideline: Diagnosis and Initial Treatment of Ischemic Stroke." This document is available from the Institute for Clinical Systems Improvement (ICSI) Web site External Web Site Policy.

For more information, contact ICSI at 8009 34th Avenue South, Suite 1200, Bloomington, MN 55425; phone: 952-814-7060; fax: 952-858-9675; Web site: www.icsi.org External Web Site Policy; e-mail: icsi.info@icsi.org.

NQMC Status

This NQMC summary was completed by ECRI Institute on November 14, 2012.

Copyright Statement

This NQMC summary (abstracted Institute for Clinical Systems Improvement [ICSI] Measure) is based on the original measure, which is subject to the measure developer's copyright restrictions.

The abstracted ICSI Measures contained in this Web site may be downloaded by any individual or organization. If the abstracted ICSI Measures are downloaded by an individual, the individual may not distribute copies to third parties.

If the abstracted ICSI Measures are downloaded by an organization, copies may be distributed to the organization's employees but may not be distributed outside of the organization without the prior written consent of the Institute for Clinical Systems Improvement, Inc.

All other copyright rights in the abstracted ICSI Measures are reserved by the Institute for Clinical Systems Improvement, Inc. The Institute for Clinical Systems Improvement, Inc. assumes no liability for any adaptations or revisions or modifications made to the abstracts of the ICSI Measures.

Disclaimer

NQMC Disclaimer

The National Quality Measures Clearinghouseâ„¢ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.

Read full disclaimer...